The Safety of a High-Dose, Rapid Infusion of Iron Sucrose
| Status: | Withdrawn |
|---|---|
| Conditions: | Iron Deficiency Anemia, Anemia |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/20/2017 |
| Start Date: | January 2017 |
| End Date: | May 2017 |
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose in a Non-Dialysis Dependent Population
Iron sucrose infusion is an iron replacement used to treat iron deficiency anemia (not enough
iron in the body to make hemoglobin). Iron is a mineral that the body needs to produce
hemoglobin, which carries oxygen in the blood. When the body does not get enough iron, it
cannot produce enough hemoglobin and you become anemic.
The research study is looking at the side effects of using a higher dose and faster rate of
iron sucrose infusion than what is used in standard of care. The purpose of this study is to
see if infusion with 500 mg of iron sucrose over a one hour time period can be done safely.
If this can be done safely, it may reduce the total number of infusions required and the time
for each infusion. This may be less costly and less burdensome to patients.
iron in the body to make hemoglobin). Iron is a mineral that the body needs to produce
hemoglobin, which carries oxygen in the blood. When the body does not get enough iron, it
cannot produce enough hemoglobin and you become anemic.
The research study is looking at the side effects of using a higher dose and faster rate of
iron sucrose infusion than what is used in standard of care. The purpose of this study is to
see if infusion with 500 mg of iron sucrose over a one hour time period can be done safely.
If this can be done safely, it may reduce the total number of infusions required and the time
for each infusion. This may be less costly and less burdensome to patients.
Inclusion Criteria:
- Any patient requiring iron infusion
Exclusion Criteria:
- Patients will be excluded from enrollment if they are under the age of 18, unable to
give signed consent, are pregnant, have end-stage renal disease, are on hemodialysis
(HD), or have a history of clinically significant adverse reactions to iron sucrose.
We found this trial at
1
site
Click here to add this to my saved trials
